Company CVAbout Granules India Ltd 
Granules India Ltd
Mid Cap
Pharmaceuticals & Drugs
Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in `first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
Company Coordinates
Company Details
Second Floor Block III, My Home Hub Madhapur Hyderabad Telangana : 500081
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 24.24 Cr
Number of Shares
24.24 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Sep-2023
24.24
24.24
325960
1
Issued under ESOP Scheme
19-Oct-2022
24.2
24.20
-6250000
1
Buy Back of Shares
11-Jul-2022
24.83
24.83
286980
1
Issued under ESOP Scheme
01-Oct-2021
24.8
24.80
330980
1
Issued under ESOP Scheme
04-Dec-2020
24.77
24.77
34000
1
Issued under ESOP Scheme
28-Sep-2020
24.76
24.76
134000
1
Issued under ESOP Scheme
11-Aug-2020
24.75
24.75
210608
1
Issued under ESOP Scheme
03-Jul-2020
24.73
24.73
150000
1
Issued under ESOP Scheme
25-Jun-2020
24.71
24.71
-7101374
1
Buy Back of Shares
31-Oct-2018
25.42
25.42
75000
1
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 27 Schemes (11.57%)
FIIs
Held by 154 FIIs (15.15%)
Promoter with highest holding
Krishna Prasad Chigurupati (31.66%)
Highest Public shareholder
Life Insurance Corporation Of India (5.27%)
Individual Investors Holdings
16.07%
Board of Directors
Management
Designation
Remuneration
C Krishna Prasad
Chairman & Managing Director
35.36 cr
A Arun Rao Akinepally
Non-Exec. & Independent Dir.
47.2 lacs
Harsha Chigurupati
Executive Director
3.54 cr
Uma Devi Chigurupati
Executive Director
3.54 cr
K B Sankara Rao
Non-Exec & Non-Independent Dir
43.3 lacs
Chaitanya Tummala
Company Sec. & Compli. Officer
0
Arun Sawhney
Non-Exec. & Independent Dir.
45.6 lacs
Saumen Chakraborty
Independent Director
41.8 lacs
Sucharita Rao Palepu
Independent Director
38.5 lacs
KVS Ram Rao
Joint Managing Director & CEO
9.46 cr
Kapil Mehan
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenue - Scrap
44.84
2.14%
Other Operating Revenue - Scrap
Other Operating Revenue - Scrap
Stock DNARevenue and Profits:
Net Sales:
1,138 Cr
(Quarterly Results - Dec 2024)
Net Profit:
118 Cr
Pharmaceuticals & Drugs
INR 10,936 Cr (Mid Cap)
22.00
33
0.35%
0.26
14.21%
3.05
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
